← FDA DRUG APPROVALS

FDA NDA · NDA017952

TRIMPEX 200

Sponsor: ROCHE

APPLICATION
NDA017952
TYPE
NDA
ORIGINAL APPROVAL
1980-05-30
LATEST ACTION
1997-07-31
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

TRIMPEX 200Discontinued
TRIMETHOPRIM 200MG · TABLET · ORAL
TRIMPEXDiscontinued
TRIMETHOPRIM 100MG · TABLET · ORAL

Approval history

1997-07-31Manufacturing (CMC) · Supplement 14 · standardAP
1990-07-17Manufacturing (CMC) · Supplement 13 · standardAP
1989-04-20Manufacturing (CMC) · Supplement 12 · standardAP
1983-08-01Manufacturing (CMC) · Supplement 9 · standardAP
1983-08-01Manufacturing (CMC) · Supplement 8 · standardAP
1983-07-11Labeling · Supplement 5 · standardAP
1983-01-26Manufacturing (CMC) · Supplement 7 · standardAP
1982-11-09Manufacturing (CMC) · Supplement 6 · standardAP
1982-07-08Labeling · Supplement 2 · standardAP
1981-10-09Manufacturing (CMC) · Supplement 4 · standardAP
1981-04-23Manufacturing (CMC) · Supplement 3 · standardAP
1980-10-28Manufacturing (CMC) · Supplement 1 · standardAP
1980-05-30Type 5 - New Formulation or New Manufacturer · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →